NIFTY Quality Low-Volatility 30

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Colgate-Palmolive (India) has informed that the Board of Directors at its Meeting held earlier today, August 21, 2026, has, 1. Noted the resignation of Prabha Narasimhan (DIN: 08822860) as the Managing Director and Chief Executive Officer of the Company effective close of business on September 27, 2026 pursuant to her promotion as the Executive Vice President - Marketing, Asia-Pacific Division of Colgate-Palmolive. 2. Based on the recommendation of the Nomination and Remuneration Committee, approved the appointment of Mr. Manish Anandani (DIN: 07257875) as the Managing Director and Chief Executive Officer of the Company for a period of 5 consecutive years effective September 28, 2026, in succession to Prabha Narasimhan. The said appointment shall be subject to the approval of Shareholders of the Company and other statutory approvals as may be applicable. Details with respect to aforementioned change, as required under Regulation 30(6) read with SEBI Circular No SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 is enclosed as Annexure A. A copy of the resignation letter received from Prabha Narasimhan is enclosed as Annexure B. The meeting of the Board of Directors commenced at 8:00 am (IST) and concluded at 8:45 am (IST).

The above information is a part of company’s filings submitted to BSE. 

Sun Pharmaceutical Industries has informed that the company and certain of its subsidiaries have been defendants in antitrust litigation in the United States relating to a 2008 patent litigation settlement agreement with Pfizer concerning generic Lipitor (Atorvastatin). Plaintiffs alleged that the settlement unlawfully delayed generic competition for Lipitor and that absent the unlawful settlement, Lipitor would have entered the market earlier than it did. The matter has been disclosed from time to time in the Company's financial statements. The United States Court of Appeals for the Third Circuit has affirmed the order of the United States District Court granting summary judgment in its entirety in favour of the Company and its subsidiaries. The Appellate Court has also affirmed the District Court's orders denying class certification as to the plaintiffs. This decision represents a significant favourable development for the Company and its subsidiaries in the matter, and brings the litigation substantially to a close, subject to any further remedies that may be available to the plaintiffs under applicable law.

The above information is a part of company’s filings submitted to BSE.